These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis. Joy MS; Matzke GR; Frye RF; Palevsky PM Am J Kidney Dis; 1998 Jun; 31(6):1019-27. PubMed ID: 9631848 [TBL] [Abstract][Full Text] [Related]
7. Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy. Akers KS; Cota JM; Chung KK; Renz EM; Mende K; Murray CK J Burn Care Res; 2012; 33(6):e254-62. PubMed ID: 22878490 [TBL] [Abstract][Full Text] [Related]
8. Accelerated Venovenous Hemofiltration as a Transitional Renal Replacement Therapy in the Intensive Care Unit. Allegretti AS; Endres P; Parris T; Zhao S; May M; Sylvia-Reardon M; Bezreh N; Culbert-Costley R; Ananian L; Roberts RJ; Lopez N; Charytan DM; Tolkoff-Rubin N Am J Nephrol; 2020; 51(4):318-326. PubMed ID: 32097936 [TBL] [Abstract][Full Text] [Related]
12. Observational clinical study on the effects of different dosing regimens on vancomycin target levels in critically ill patients: Continuous versus intermittent application. Tafelski S; Nachtigall I; Troeger U; Deja M; Krannich A; Günzel K; Spies C; J Infect Public Health; 2015; 8(4):355-63. PubMed ID: 25794497 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis. Kielstein JT; Czock D; Schöpke T; Hafer C; Bode-Böger SM; Kuse E; Keller F; Fliser D Crit Care Med; 2006 Jan; 34(1):51-6. PubMed ID: 16374156 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of vancomycin when administered during high flux hemodialysis. Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347 [TBL] [Abstract][Full Text] [Related]
15. An update on vancomycin dosing and monitoring practices in hemodialysis patients. Zhang M; Dresser L; Battistella M CANNT J; 2013; 23(4):25-7; quiz 28-9. PubMed ID: 24660521 [No Abstract] [Full Text] [Related]
16. Evaluation of Continuous Infusion Vancomycin Administration in a Critically Ill Trauma Population. Bissell BD; Riggi G; Morrison C J Intensive Care Med; 2020 Jun; 35(6):570-575. PubMed ID: 29642744 [TBL] [Abstract][Full Text] [Related]
17. Vancomycin during the Last Hour of the Hemodialysis Session: A Pharmacokinetic Analysis. Ghouti-Terki L; Chasseuil E; Rabot N; Paintaud G; François M; Birmelé B; Darrouzain F; Büchler M; Halimi JM; Ternant D Nephron; 2017; 135(4):261-267. PubMed ID: 28152540 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis. Connor MJ; Salem C; Bauer SR; Hofmann CL; Groszek J; Butler R; Rehm SJ; Fissell WH Antimicrob Agents Chemother; 2011 Feb; 55(2):557-60. PubMed ID: 21115798 [TBL] [Abstract][Full Text] [Related]